CABA
Cabaletta Bio Inc.
$3.61
+$1.14(+46.15%)
57
Overall
60
Value
91
Tech
21
Quality
Market Cap
$250.61M
Volume
35.91M
52W Range
$0.99 - $5.46
Target Price
$11.56
Order:
Income Statement
| Metric | Trend | Chart | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|
| OPERATING EXPENSES | ||||||||
| Operating Expenses | $18.7M | $33.8M | $46.3M | $54.1M | $74.7M | $125.1M | ||
| Research & Development | $11.7M | $21.4M | $32.5M | $39.3M | $55.4M | $97.2M | ||
| Research Expense | $11.7M | $21.4M | $32.5M | $39.3M | $55.4M | $97.2M | ||
| Selling, General & Administrative | $7.0M | $12.5M | $13.8M | $14.8M | $19.2M | $27.9M | ||
| General & Administrative Expenses | $7.0M | $12.5M | $13.8M | $14.8M | $19.2M | $27.9M | ||
| Depreciation & Amortization | $-104.0K | $354.0K | $733.0K | $1.2M | $1.4M | $1.7M | ||
| Depreciation & Amortization | $-104.0K | $354.0K | $733.0K | $1.2M | $1.4M | $1.7M | ||
| Other Operating Expenses | -- | -- | $752.0K | $3.8M | $3.3M | $4.3M | ||
| OPERATING INCOME | ||||||||
| Operating income | $-18.7M | $-33.8M | $-46.3M | $-54.1M | $-74.7M | $-125.1M | ||
| EBITDA | $-22.2M | $-33.5M | $-45.6M | $-53.0M | $-66.2M | $-110.3M | ||
| NON-OPERATING ITEMS | ||||||||
| Interest Expense (Non-Operating) | -- | -- | -- | -- | -- | $748.0K | ||
| Intinc | $1.7M | $494.0K | $24.0K | $1.2M | $7.0M | $10.0M | ||
| Net Non-Operating Interest Income/Expense | $1.7M | $494.0K | $24.0K | $1.2M | $7.0M | $9.3M | ||
| Other Income/Expense | $5.3M | $-6.0K | $6.0K | $47.0K | $-86.0K | $39.0K | ||
| Other Special Charges | -- | -- | -- | $5.1M | $5.0M | -- | ||
| PRE-TAX INCOME | ||||||||
| EBIT | $-22.3M | $-33.8M | $-46.3M | $-54.1M | $-67.7M | $-115.1M | ||
| Pre-Tax Income | $-22.3M | $-33.3M | $-46.3M | $-53.0M | $-67.7M | $-115.9M | ||
| NET INCOME | ||||||||
| Net Income | $-22.3M | $-33.3M | $-46.3M | $-53.0M | $-67.7M | $-115.9M | ||
| Net Income (Continuing Operations) | $-22.3M | $-33.3M | $-46.3M | $-53.0M | $-67.7M | $-115.9M | ||
| Net Income (Discontinued Operations) | $-22.3M | $-33.3M | $-46.3M | $-53.0M | $-67.7M | $-115.9M | ||
| Net Income (Common Stockholders) | $-22.3M | $-33.3M | $-46.3M | $-53.0M | $-67.7M | $-115.9M | ||
| Normalized Income | -- | -- | $-36.6M | -- | -- | $-114.7M | ||
| TOTALS | ||||||||
| Total Expenses | $18.7M | $33.8M | $46.3M | $54.1M | $74.7M | $125.1M | ||
| SHARE & EPS DATA | ||||||||
| Average Shares Outstanding | $5.5M | $23.2M | $25.7M | $5.9M | $1.2M | $49.5M | ||
| Average Shares Outstanding (Diluted) | $5.5M | $23.2M | $25.7M | $5.9M | $1.2M | $49.5M | ||
| Shares Outstanding | $24.0M | $24.1M | $29.0M | $91.5M | $91.5M | $50.7M | ||
| Basic EPS | $-4.07 | $-1.44 | $-1.8 | $-1.81 | $-1.65 | $-2.34 | ||
| Basic EPS (Continuing Operations) | $-4.07 | $-1.44 | $-1.8 | $-1.81 | $-1.65 | $-2.34 | ||
| Diluted EPS | $-4.07 | $-1.44 | $-1.8 | $-1.81 | $-1.65 | $-2.34 | ||
| Diluted EPS (Continuing Operations) | -- | -- | -- | $-1.81 | $-1.65 | $-2.34 | ||
| OTHER METRICS | ||||||||
| Earnings from equity interest | $-5.3M | -- | -- | -- | -- | -- | ||
| Earnings From Equity Interest Net Of Tax | $-5.3M | -- | -- | -- | -- | -- | ||
| Other Gand A | $7.0M | $12.5M | $13.8M | $14.8M | $19.2M | $27.9M | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CABA | $3.61 | +46.2% | 35.91M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |